Skip to main navigation
Adamis
  • Contact Us
Select Page
  • About
    • Overview
    • Management
    • Board of Directors
  • Products
  • Pipeline
    • Specialty Pharmaceuticals
    • APC – 1000
    • APC – 4000
    • APC – 6000
    • APC – 8000
  • Investors

    Investor Relations

    • Investors
    • Overview
    • News Releases
    • Stock Information
    • SEC Filings
    • Events and Presentations
    • Email Alerts
    • Governance
  • Careers
    • Partnerships
  • Contact Us

SEC Filing Details

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts
  • Governance

Tools

  • Print Page

SEC Filing Details

Document Details

Form
8-K
Filing Date
Jun 17, 2022
Document Date
Jun 17, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Adamis Pharmaceuticals Corporation
Issuer
ADAMIS PHARMACEUTICALS CORP

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT
Adamis
  • About

  • Management
  • Board of Directors
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in the therapeutic areas of respiratory disease and allergy.
  • Twitter
  • LinkedIn
  • Customized Medications

  • Products

  • Pipeline

  • Specialty Pharmaceuticals
    • APC – 6000
    • APC – 8000
  • Metered Dose Inhalers
    • APC – 1000
  • Dry Powder Inhaler Platform
    • APC – 4000
  • Partnerships

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts
  • Governance
  • Careers
  • Partnerships
  • Contact Us

858.997.2400
  • Privacy Statement
  • Terms of Use

2022 Copyright Adamis Pharmaceuticals Corporation